Madryn Health Partners, LP's Form 4 filing
Venus Concept Inc. (VERO) · filed Mar 30, 2026
- Accession no.
- 0001193125-26-132846
- Filed
- Mar 30, 2026, 9:16 PM ET
- Trade date
- Mar 26, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 4 derivative transactions. Open-market purchases total $1.50M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Madryn Health Partners, LPCIK 0001650490 | 10% Owner |
| Madryn Asset Management, LPCIK 0001787423 | 10% Owner |
| Madryn Health Advisors, LPCIK 0001836559 | 10% Owner |
| Madryn Health Partners (Cayman Master), LPCIK 0001836788 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 26, 2026 | Common Stock | PPurchaseAcquired | +90,900 | –F6 | – | 1,500,000 | Indirect | |
| Mar 26, 2026 | Common Stock | PPurchaseAcquired | +381,976 | –F6 | – | 1,575,810 | Indirect | |
| Mar 26, 2026 | Common Stock | PPurchaseAcquired | +189,756 | –F6 | – | – | Indirect | |
| Mar 26, 2026 | Common Stock | PPurchaseAcquired | +20,301 | –F4 | – | 1,835,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Pursuant to a Stock Purchase Agreement, dated March 26, 2026, by and among Madryn Health Partners, LP ("MHP"), Madryn Health Partners (Cayman Master), LP ("MHP Cayman" and together with MHP, the "Funds"), and the Issuer, the Issuer sold to the Funds an aggregate of 37,500,000 shares of common stock for an aggregate purchase price of $1,500,000.
Referenced by the price of 1 transaction in Table I.
- F4
Pursuant to a Securities Purchase Agreement, dated March 26, 2026, by and among the Funds and HealthQuest Partners II L.P. ("HealthQuest"), HealthQuest sold to the Funds the shares of Common Stock and Voting Convertible Preferred Stock reported herein as sold by HealthQuest to the Funds for consideration in the form of promissory notes representing an aggregate principal balance payable by the Funds to HealthQuest of $755,646.90, allocated $754,159.42 to the Voting Convertible Stock sold thereunder and $1,487.48 to the Common Stock sold thereunder.
Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.
- F6
Pursuant to a Securities Purchase Agreement (the "EW SPA"), dated March 26, 2026, by and among EW Healthcare Partners, L.P. ("EWHP"), EW Healthcare Partners-A, L.P. ("EWHP-A" and, together with EWHP, the "EWHP Funds"), Madryn Health Partners, LP ("MHP"), Madryn Health Partners (Cayman Master), LP ("MHP Cayman" and together with MHP, the "Funds"), and the other parties thereto, the EWHP Funds sold to the Funds the shares of Senior Convertible Preferred Stock, Voting Convertible Preferred Stock and Secured Subordinated Convertible Notes reported herein as sold by the EWHP Funds to the Funds for an aggregate sale price of $2,600,000.
Referenced by the price of 3 transactions in Table II.